Atropine Sulfate Preservative-Free Ophthalmic Solution
Available concentrations: 0.01%, 0.025% and 0.05%
Quantity: 7 mL
Price: Call 833.540.3500 or login to the Practitioner Portal for pricing.
Sig: Place one drop in each eye every night at bedtime.
Sterile compounded ophthalmic preparation available by prescription. The FDA does not review any compounded medication for safety or efficacy.
What is Atropine Sulfate Preservative-Free Ophthalmic Solution?
Atropine sulfate ophthalmic solution is a compounded preservative-free sterile eye drop available in multiple low-dose concentrations.
Atropine is an anticholinergic agent that affects the eye’s focusing mechanism and pupil size. In ophthalmology, low-dose formulations are most commonly associated with myopia management, while higher concentrations have historically been used for cycloplegia and dilation.
Compounding allows for customized concentrations and preservative-free formulations tailored to patient-specific needs.
What is the Mechanism of Action?
Atropine works by blocking muscarinic receptors in the eye, which leads to:
- Relaxation of the ciliary muscle (cycloplegia)
- Pupil dilation (mydriasis)
- Modulation of ocular growth signals (in myopia management applications)
While the exact mechanism for myopia control is not fully understood, it is believed that atropine influences biochemical pathways involved in axial elongation of the eye, which is a key driver of myopia progression.
Clinical Scenarios Where Ophthalmologists Explore Atropine Sulfate Eye Drops
Ophthalmologists and optometrists may consider low-dose atropine in scenarios such as:
- Myopia management in pediatric patients
- Progressive nearsightedness requiring intervention
- Patients intolerant to preservatives in commercial formulations
- Customized dosing strategies, where different concentrations are clinically appropriate
- Long-term management plans where lower concentrations may balance efficacy and tolerability
Treatment decisions are individualized based on patient age, progression rate, and provider preference.
Why Ophthalmologists Choose Massey Drugs
- Sterile compounding laboratory experienced in ophthalmic preparations
- Preservative-free formulations tailored for ocular use
- Direct pharmacist access for clinical questions
- Fast turnaround with patient shipment typically within 24–48 hours
- Experience working with corneal specialists and surgical practices
- NABP Accredited Compounding Pharmacy
States We Serve
Massey Drugs is a sterile ophthalmic compounding pharmacy licensed to ship ophthalmic solutions to patients in: Alabama, Tennessee, Mississippi, Louisiana, Georgia, Florida, North Carolina, South Carolina, Kentucky, Illinois, Indiana, Ohio, Pennsylvania, New York, Connecticut, and Texas.
How to Prescribe Atropine Sulfate Preservative-Free Ophthalmic Solution
Download Rx Blank from the Practitioner Portal and send to Massey Drugs:
FAX: 800.637.2601
Phone: 833.540.3500
OR
e-Scribe: NPI#: 1295756245 | NCPCP#: 0127553
Massey Drugs | Cloverdale Road
Upon receipt of prescription, Massey Drugs contacts the patient to confirm shipping address and credit card payment.
Medication ships to patient in 24-48 hours once processed.
Massey Drugs provides competitively priced compounded ophthalmic eye drops with transparent, prescriber-accessible pricing. All compound pricing can be viewed in our Practitioner Portal so costs can be communicated to patients before prescribing.
Speak with a Pharmacist
If you have questions about ophthalmic compounding, formulation options, or whether this therapy may be appropriate for a specific clinical scenario, our pharmacists are available to consult. Call 833-540-3500 or contact us.
Frequentley Asked Questions
What are atropine eye drops used for?
Low-dose atropine eye drops are commonly explored in ophthalmology for myopia management, particularly in children with progressive nearsightedness.
What is the difference between 0.01%, 0.025%, and 0.05% atropine?
These concentrations represent different dosing strengths. Providers may adjust concentration based on the patient’s response, progression rate, and tolerance.
Who is a candidate for atropine therapy?
Patients with progressive myopia, especially children, may be considered based on provider evaluation.
Additional Ophthalmic Compounding Capabilities
We compound additional sterile ophthalmic therapies used for:
- Post-operative Care
- Emergency & Infection Management
- Emergency & Corneal Scarring Support
- Glaucoma Compounding
- Myopia Management
Explore our full range of ophthalmic compounding capabilities.